Payer PolicyActive
CG-MED-88 Preimplantation Embryo Biopsy
ANTHEM-CG-MED-88
Anthem
Effective: April 16, 2025
Updated: December 30, 2025
Policy Summary
This policy addresses preimplantation embryo biopsy, the removal of embryonic cells during IVF for preimplantation genetic testing (PGT). It is covered as medically necessary only when performed for PGT that meets the plan’s applicable guidelines; it is not medically necessary when those criteria are not met. Coverage is limited to indications consistent with plan-approved PGT guidelines (e.g., testing to reduce risk of inherited genetic disorders or chromosomal abnormalities).
Coverage Criteria Preview
Key requirements from the full policy
"Preimplantation embryo biopsy is consideredmedically necessarywhen conducted for preimplantation genetic testing that meets the applicable guidelines used by the plan."
Sign up to see full coverage criteria, indications, and limitations.